Kappa and lambda FLC expression showed significant negative correlations with tumor-relevant markers usually associated with favorable clinical outcome including the hormonal receptor markers for estrogen and progesterone and the apoptotic marker Bcl2 (p<0.001). This evidence concerns the gene BCL2 and neoplasm.